LMS Appoints Dr. Eric Knox to Risk and Patient Safety Advisory Board
May 10 2005 - 1:13PM
PR Newswire (US)
LMS Appoints Dr. Eric Knox to Risk and Patient Safety Advisory
Board MONTREAL, May 10 /PRNewswire-FirstCall/ -- LMS Medical
Systems (AMEX:LMZ; TSX:LMZ), a healthcare technology company and
developer of the CALM(TM) system (Computer Assisted Labor
Management), today announced the appointment of Dr. Eric Knox to
the LMS Risk and Patient Safety Advisory Board. Dr. Knox is a
professor of obstetrics and gynecology at the University of
Minnesota where his research has focused on High Reliability and
Teamwork in preventing perinatal injury and malpractice claims. He
has published over 100 articles concerning clinical practice and
management of clinical risk. Currently, he is doing
multidisciplinary qualitative research on patterns of
nurse-physician communication and their effect on patient injury in
obstetrics. Dr. Knox has practiced obstetrics for over 20 years in
various positions and cadres and is the former Director of Patient
Safety and Risk Management at Children's Hospitals and Clinics of
Minnesota in Minneapolis and St. Paul. He was a founding Board
member of the National Patient Safety Foundation. He currently
consults actively with groups such as a university based medical
malpractice insurance captive and large healthcare organizations
throughout the United States. Patient safety is a cornerstone of
high quality clinical care. Over the past few years, landmark
reports such as the Institute of Medicine's To Err is Human has
rekindled the attention of caregivers, providers, insurers,
patients and even government officials to the prevalence and
consequences of error in healthcare today. Obstetrics is not immune
to this. In fact, studies report that 30 to 50 percent of adverse
outcomes in OB could be preventable. LMS specializes in risk
management tools for clinicians and managers. The CALM tools
incorporate statistical processes to quantify normal and abnormal
labor progression as well as digital signal processing and neural
network applications for the identification of abnormal fetal heart
rate patterns. The CALM Curve provides for consistent and objective
assessment of the labor progress at the bedside. CALM Patterns
provides objective, real-time measurement and classification of
fetal heart rate patterns. These tools address themes commonly
found in adverse outcomes namely, failure to recognize and respond
to abnormal tracings and prolonged labor. "Dr. Knox has
demonstrated leadership in the area of patient safety throughout
his career and we are privileged to have him bring this special
focus to the Advisory Board," said Dr. Emily Hamilton, Founder and
Chief Medical Officer of LMS. "His insight into the human factors
and dynamics of healthcare will be a useful and valuable complement
to the perspective of other Board members." About LMS: LMS Medical
Systems is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS Computer
Assisted Labor Management product suite provides physicians,
nursing staff and risk managers with innovative obstetrical
decision support and risk management tools integrated into robust
clinical information systems designed to improve outcomes and
patient care for mothers and their infants during labor and
delivery. This press release contains forward-looking statements
that involve risks and uncertainties, which may cause actual
results to differ materially from the statements made. For this
purpose, any statements that are contained herein that are not
statements of historical fact may be deemed to be forward- looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Without limiting
the foregoing, the words "believes," "anticipates," "plans,"
"intends," "will," "should," "expects," "projects," and similar
expressions are intended to identify forward-looking statements.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause actual results, future
circumstances, or events to differ materially from those projected
in the forward-looking statements. These risks include, but are not
limited to, those associated with the success of research and
development programs, the adequacy, timing, and results of clinical
trials, the regulatory approval process, competition, securing and
maintaining corporate alliances, market acceptance of the Company's
products, the strength of intellectual property, financing
capability, the potential dilutive effects of any financing,
reliance on subcontractors and key personnel, and other risks
detailed from time-to-time in the Company's public disclosure
documents or other filings with the Canadian and U.S. securities
commissions or other securities regulatory bodies. The
forward-looking statements are made as of the date hereof, and the
Company disclaims any intention and has no obligation or
responsibility, except as required by law, to update or revise any
forward- looking statements, whether as a result of new
information, future events, or otherwise. DATASOURCE: LMS MEDICAL
SYSTEMS INC. CONTACT: Andrea Miller, Communications, LMS Medical
Systems Inc., (514) 488-3461 Ext. 222, Fax: (514) 488-1880, E-mail
; Website: http://www.lmsmedical.com/
Copyright